Effect of lithium carbonate in HIV-infected patients with immune dysfunction.

David M. Parenti(Washington University Medical Center), R S Schulof(Uniformed Services University of the Health Sciences), William A. Meyer(Quest Diagnostics (United States)), R A DiGioia, R G Scheib, Helene Paxton, G L Simon, Marcelo B. Sztein(University of Maryland, Baltimore)

PubMed

January 1, 1988

Cited by 30

Related Papers

Risk Factors for Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Women Treated with Zidovudine

|New England Journal of Medicine|1999|553

Serum Levels of the Proinflammatory Cytokines Interleukin-1 Beta (IL-1β), IL-6, IL-8, IL-10, Tumor Necrosis Factor Alpha, and IL-12(p70) in Malian Children with Severe<i>Plasmodium falciparum</i>Malaria and Matched Uncomplicated Malaria or Healthy Controls

|Infection and Immunity|2004|447

Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road

|Nature Reviews Microbiology|2007|372

The Relationship between Serum Human Immunodeficiency Virus Type 1 (HIV‐1) RNA Level, CD4 Lymphocyte Percent, and Long‐Term Mortality Risk in HIV‐1—Infected Children

|The Journal of Infectious Diseases|1997|265

Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans

|Infection and Immunity|1997|251